e-mirgency
e-miRgency está transformando la monitorización del cáncer al convertir una simple extracción de sangre en información molecular rápida y útil, lo que facilita la realización de…
- Raising on Capital Cell
- Diagnóstico · France
The raise in figures
Raised
€708,292
of €1,000,000 target
70%
funded
- Investors
- 51
- Minimum investment
- €1,000
- Pre-money valuation
- €5.9M
- Time left
- 53 days
At target: €6.9M post-money · 14.52% equity offered
Last updated
↳ Capital Cell · checked just now
About this raise
e-mirgency has an open equity crowdfunding raise on Capital Cell. The company is based in France, and Capital Cell lists it under Diagnóstico. The round is made under the EU’s European Crowdfunding Service Providers Regulation (ECSPR).
The pre-money valuation is €5.88M. e-mirgency set a target of €1M. So far it has raised €708,292 from 51 investors, 70% of its target. Investors can put in as little as €1,000.
It closes on . It is open to investors outside Spain, within Capital Cell’s eligibility rules.
ECSPR sets one set of rules for licensed crowdfunding platforms across the EU, including what a raise has to disclose to investors. Raise Sonar last read these figures from Capital Cell on .
Live
Closes in 53 days
Funding history
193 readings
About e-mirgency
Summarised by Raise Sonar from e-mirgency’s Capital Cell pitch
e-miRgency is developing a blood test that gives molecular results on microRNA in under 30 minutes, aimed at more frequent cancer treatment monitoring. The platform is protected by two patents and developed from more than 10 years of CNRS research, with clinical partners Gustave Roussy and INSERM. Revenue is planned from a disposable test chip sold with an instrument, followed by custom panels, services and licences. This raise of 2 million euros funds industrialisation, clinical validation, regulatory preparation and initial commercial deployment.
Read the full pitch on Capital Cell (opens in a new tab)More like this
Questions about e-mirgency’s raise
When does e-mirgency’s crowdfunding raise close?
e-mirgency’s raise on Capital Cell closes on Sunday 27 December 2026 at 22:59 GMT.
What is the minimum investment in e-mirgency?
The minimum investment in e-mirgency’s raise on Capital Cell is €1,000.
Can I invest in e-mirgency from outside Spain?
Yes. Capital Cell accepts investors from outside Spain for this raise, subject to its own eligibility checks.
What regulation is e-mirgency’s raise under?
e-mirgency’s raise is under the EU’s European Crowdfunding Service Providers Regulation (ECSPR). ECSPR is the EU-wide regulation for licensed crowdfunding platforms, and it requires a key investment information sheet (KIIS) for every raise.
How much has e-mirgency raised so far?
As of 4 November 2026, e-mirgency has raised €708,292 from 51 investors on Capital Cell, 70% of its €1M target.
Your close reminders
Closes Sun 27 Dec
- Next: 7 days Sun 20 Dec
- 72-hour alert Thu 24 Dec
- 24-hour alert Sat 26 Dec
- Close Sun 27
More raises on Capital Cell
All Capital Cell raisesLive now
-
VRAIn Medical
9 days leftTransformamos al instante imágenes médicas complejas en Digital Immersive Twins (DITs) que especialistas y pacientes pueden entender.
Details of VRAIn Medical120% funded
closes Fri 13 Nov
-
fetaLife
32 days leftUna solución revolucionaria para dar soporte a la vida de los bebés más prematuros.
Details of fetaLife67% funded
closes Sun 6 Dec
About Raise Sonar
Every live equity crowdfunding raise, in one place
We track raises across Crowdcube, Republic, Wefunder, StartEngine and more, and tell you when they open and before they close.
- 610 live raises now, all in the Raise Sonar app
- 26 platforms in 12 countries
- ~2 new raises a day
-
Launch alerts
An email when a raise matching your filters opens.
-
Close reminders
Follow a raise and hear from us 72 and 24 hours before it closes.
-
One search, every platform
Filter live raises by sector, country, minimum and platform.
-
The weekly newsletter
New raises and raises closing soon, every Monday.